Search research articles
Contact Us
Filters
Showing results (101-110 of 282) with videos related to
Page
of 29
Sort By:
The Journal of Sexual Medicine
|
February 9, 2016
Health-Related Quality of Life, Psychological Distress, and Sexual Changes Following Prostate Cancer: A Comparison of Gay and Bisexual Men with Heterosexual Men
Jane M Ussher, Janette Perz, Andrew Kellett, et al.
The Prostate
|
October 23, 2008
Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy
Marcus P Kelly, Sze Ting Lee, F-T Lee, et al.
BJU International
|
September 9, 2014
The Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group--a new co-operative cancer trials group in genitourinary oncology
Shomik Sengupta, Peter Grimison, Dickon Hayne, et al.
BJU International
|
November 5, 2025
Target trial emulation of early docetaxel and enzalutamide for metastatic hormone-sensitive prostate cancer
Yu Yang Soon, Ian C Marschner, I Manjula Schou, et al.
The Medical Journal of Australia
|
May 26, 2018
Active surveillance of men with low risk prostate cancer: evidence from the Prostate Cancer Outcomes Registry-Victoria
Melanie A Evans, Jeremy L Millar, Arul Earnest, et al.
JAMA Network Open
|
September 17, 2024
Lu-177 PSMA vs Comparator Treatments and Survival in Metastatic Castration-Resistant Prostate Cancer
Yu Yang Soon, Ian C Marschner, Manjula Schou, et al.
BJU International
|
December 21, 2012
Intravesical chemotherapy plus bacille Calmette-Guérin in non-muscle invasive bladder cancer: a systematic review with meta-analysis
Baerin B Houghton, Venu Chalasani, Dickon Hayne, et al.
Cancer Immunology, Immunotherapy : CII
|
February 18, 2009
Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells
Craig Gedye, Juliet Quirk, Judy Browning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 14, 2008
Predicting clinical outcome through molecular profiling in stage III melanoma
Thomas John, Michael A Black, Tumi T Toro, et al.
American Journal of Clinical Oncology
|
April 14, 2009
An open-label, single-arm phase two trial of gefitinib in patients with advanced or metastatic castration-resistant prostate cancer
Carmel Pezaro, Mark A Rosenthal, Howard Gurney, et al.
Page
of 29
Search research articles
Search
Showing results (101-110 of 282) with videos related to
Sort By:
Page
of 29
The Journal of Sexual Medicine
|
February 9, 2016
Health-Related Quality of Life, Psychological Distress, and Sexual Changes Following Prostate Cancer: A Comparison of Gay and Bisexual Men with Heterosexual Men
Jane M Ussher, Janette Perz, Andrew Kellett, et al.
The Prostate
|
October 23, 2008
Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy
Marcus P Kelly, Sze Ting Lee, F-T Lee, et al.
BJU International
|
September 9, 2014
The Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group--a new co-operative cancer trials group in genitourinary oncology
Shomik Sengupta, Peter Grimison, Dickon Hayne, et al.
BJU International
|
November 5, 2025
Target trial emulation of early docetaxel and enzalutamide for metastatic hormone-sensitive prostate cancer
Yu Yang Soon, Ian C Marschner, I Manjula Schou, et al.
The Medical Journal of Australia
|
May 26, 2018
Active surveillance of men with low risk prostate cancer: evidence from the Prostate Cancer Outcomes Registry-Victoria
Melanie A Evans, Jeremy L Millar, Arul Earnest, et al.
JAMA Network Open
|
September 17, 2024
Lu-177 PSMA vs Comparator Treatments and Survival in Metastatic Castration-Resistant Prostate Cancer
Yu Yang Soon, Ian C Marschner, Manjula Schou, et al.
BJU International
|
December 21, 2012
Intravesical chemotherapy plus bacille Calmette-Guérin in non-muscle invasive bladder cancer: a systematic review with meta-analysis
Baerin B Houghton, Venu Chalasani, Dickon Hayne, et al.
Cancer Immunology, Immunotherapy : CII
|
February 18, 2009
Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells
Craig Gedye, Juliet Quirk, Judy Browning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 14, 2008
Predicting clinical outcome through molecular profiling in stage III melanoma
Thomas John, Michael A Black, Tumi T Toro, et al.
American Journal of Clinical Oncology
|
April 14, 2009
An open-label, single-arm phase two trial of gefitinib in patients with advanced or metastatic castration-resistant prostate cancer
Carmel Pezaro, Mark A Rosenthal, Howard Gurney, et al.
Page
of 29